A 34-year-old man with a 5-year history of severe heroin use disorder presents to an outpatient addiction clinic seeking treatment. He reports that his last heroin use was 2 hours ago. He is highly motivated to stop using illicit opioids and requests to start buprenorphine/naloxone therapy immediately. To appropriately initiate and maintain his treatment while avoiding iatrogenic complications, arrange the following management steps in the correct chronological sequence.
- 1Instruct the patient to delay induction until sufficient time has elapsed to allow clearance of the full agonist
- 2Verify the emergence of objective signs of mild-to-moderate opioid withdrawal using a standardized clinical scale
- 3Administer the initial sublingual test dose of buprenorphine/naloxone
- 4Titrate the medication dosage upward over several days to suppress illicit opioid cravings
- 5Establish a long-term care plan integrating maintenance pharmacotherapy with behavioral counseling
Answer
The correct chronological sequence is to first delay the induction, verify objective signs of withdrawal, administer the initial dose, titrate the dose upward, and finally establish long-term maintenance.
Buprenorphine is a partial agonist with very high affinity for the mu-opioid receptor. If administered while a full agonist (like heroin) is still occupying the receptors, buprenorphine competitively displaces the heroin but provides less receptor activation, immediately causing severe 'precipitated withdrawal'. Therefore, the first step is to delay induction until the full agonist has cleared. Second, the clinician must objectively verify the onset of spontaneous withdrawal (e.g., using a standardized scale). Only then is the initial test dose administered. Once induction is successful, the dose is titrated to suppress cravings, followed by long-term maintenance combined with psychosocial support.
Step-by-Step Solution
Key Concept
Buprenorphine Induction and Prevention of Precipitated Withdrawal
Estimated Time:1m 30s